| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8946444 | Current Opinion in Endocrine and Metabolic Research | 2018 | 6 Pages |
Abstract
- The most frequent sellar metastases are from breast and lung cancers.
- Diabetes insipidus and abnormal eye motility are the most specific symptoms.
- Contrast-enhancing tumors with stalk thickening are suspect of metastasis.
- Ipilimumab can cause hypophysitis, hypopituitarism, but rarely diabetes insipidus.
- PET-CT cannot distinguish metastasis from adenomas or inflammatory lesions.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Monike L. Dias, Julio Abucham,